EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMSIG00000028273
Gene Symbol: AVPR1A
1 Cross references
279 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMSIG00000024504
Gene Symbol: AVPR1B
1 Cross references
149 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMSIG00000010047
Gene Symbol: AVPR2
1 Cross references
246 Possible Orthologues:

Ataxia Telangiectasia And Rad3 Related

Ensembl ID : ENSMSIG00000016256
Gene Symbol: ATR
1 Cross references
221 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMSIG00000009349
Gene Symbol: AURKB
1 Cross references
220 Possible Orthologues:

Beta-Site App Cleaving Enzyme 1

Ensembl ID : ENSMSIG00000010582
Gene Symbol: BACE1
1 Cross references
232 Possible Orthologues:

Bradykinin Receptor, Beta 1

Ensembl ID : ENSMSIG00000009831
Gene Symbol: BDKRB1
1 Cross references
162 Possible Orthologues:

Bradykinin Receptor, Beta 2

Ensembl ID : ENSMSIG00000009815
Gene Symbol: BDKRB2
1 Cross references
371 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSMSIG00000013531
Gene Symbol: BCHE
1 Cross references
145 Possible Orthologues:

C-Abl Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSMSIG00000019810
Gene Symbol: ABL1
1 Cross references
217 Possible Orthologues:

Calcitonin Receptor-Like

Ensembl ID : ENSMSIG00000003856
Gene Symbol: CALCRL
1 Cross references
161 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSMSIG00000005349
Gene Symbol: CACNA1C
1 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).